|
Volumn 90, Issue 5, 2008, Pages 663-670
|
Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin
|
Author keywords
Chitosan; Dalargin; Dextran sulfate; Nanoparticles; Sulfobutyl ether 7 cyclodextrin
|
Indexed keywords
ANIONIC ADDITIVES;
CHITOSAN NANOPARTICLES;
COMPLEX COACERVATIONS;
CONTROLLED RELEASE;
DALARGIN;
DELIVERY SYSTEMS;
DEXTRAN SULFATE;
ENHANCED STABILITIES;
ENTRAPMENT EFFICIENCIES;
GENE THERAPIES;
IONIC ADDITIVES;
LOADING EFFICIENCIES;
NANOPARTICLE FORMULATIONS;
PHYSICAL CHARACTERISTICS;
SMALL PARTICLE SIZES;
SUSTAINED RELEASE;
WEIGHT RATIOS;
ADDITIVES;
CHITIN;
CHITOSAN;
CONTROLLED DRUG DELIVERY;
DATA STORAGE EQUIPMENT;
DEXTRAN;
DIELECTRIC RELAXATION;
DRUG THERAPY;
ETHERS;
GENETIC ENGINEERING;
GLUCOSE;
ORGANIC COMPOUNDS;
PARTICLE SIZE;
SYSTEM STABILITY;
ZETA POTENTIAL;
NANOPARTICLES;
BETA CYCLODEXTRIN SULFOBUTYL ETHER;
CHITOSAN;
DEXTRAN SULFATE;
DRUG ADDITIVE;
HEXAPEPTIDE;
LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE];
NANOPARTICLE;
BETA CYCLODEXTRIN DERIVATIVE;
DRUG DERIVATIVE;
ENKEPHALIN LEU, ALA(2) ARG(6);
ENKEPHALIN-LEU, ALA(2)-ARG(6)-;
ENKEPHALIN[2 ALANINE 5 LEUCINE];
SBE4 BETA CYCLODEXTRIN;
SBE4-BETA-CYCLODEXTRIN;
UNCLASSIFIED DRUG;
COACERVATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG RELEASE;
DRUG STABILITY;
DRUG STRUCTURE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYDROPHILICITY;
PARTICLE SIZE;
SUSTAINED RELEASE FORMULATION;
ZETA POTENTIAL;
ARTICLE;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG DOSAGE FORM;
MOLECULAR WEIGHT;
BETA-CYCLODEXTRINS;
CHEMISTRY, PHARMACEUTICAL;
CHITOSAN;
DEXTRAN SULFATE;
DOSAGE FORMS;
DRUG DELIVERY SYSTEMS;
ENKEPHALIN, LEUCINE-2-ALANINE;
MOLECULAR WEIGHT;
NANOPARTICLES;
PARTICLE SIZE;
|
EID: 58149176592
PISSN: 00063525
EISSN: 10970282
Source Type: Journal
DOI: 10.1002/bip.21055 Document Type: Conference Paper |
Times cited : (32)
|
References (22)
|